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Abstract. Genetically encoded contrast in photoacoustic imaging (PAI) is complementary to the intrinsic
contrast provided by endogenous absorbing chromophores such as hemoglobin. The use of reporter genes
expressing absorbing proteins opens the possibility of visualizing dynamic cellular and molecular processes.
This is an enticing prospect but brings with it challenges and limitations associated with generating and detecting
different types of reporters. The purpose of this review is to compare existing PAI reporters and signal detection
strategies, thereby offering a practical guide, particularly for the nonbiologist, to choosing the most appropriate
reporter for maximum sensitivity in the biological and technological system of interest. © 2017 Society of Photo-Optical
Instrumentation Engineers (SPIE) [DOI: 10.1117/1.JBO.22.7.070901]
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1 Introduction
Combining optical excitation and acoustic detection, photo-
acoustic imaging (PAI) combines the high contrast available
from optical imaging with the spatiotemporal resolution of ultra-
sound imaging. Conventional reporter genes (RGs) for optical
imaging generate diffuse bioluminescence or fluorescence
signals, which can be imaged with spatial resolutions that are
typically comparable to, or worse than, the imaging depth.1,2
PAI transcends the depth limitations of optical imaging
techniques that employ ballistic photons (Fig. 1) because
acoustic waves are scattered far less than photons in tissue.
The contrast in PAI arises due to optical absorption, for example
by endogenous chromophores such as hemoglobin and melanin.
However, to directly visualize most cellular and molecular proc-
esses, the image contrast must be provided by exogenous agents.3
A RG is an exogenous segment of DNA that encodes a protein
product that, once expressed, can be visualized, either directly or
indirectly, using imaging or chemical analysis. The application of
RGs in optical imaging, magnetic resonance imaging (MRI), and
nuclear medicine has been reviewed elsewhere.4,5 PAI RGs have
been reviewed from the perspective of PAI technology;6 here, we
provide a complementary practical guide to PAI RGs for the
physical scientist, who may be unfamiliar with the biological
background and the fundamental limitations. We highlight,
in particular, the challenges of: biological RG production and
characteristics (Sec. 3); spectral unmixing of the reporter signal
(Sec. 4); and detection sensitivity (Sec. 5).
2 Principles of Photoacoustic Imaging
PAI starts with the excitation of molecules in biological tissues
following absorption of photons from pulsed or modulated
continuous-wave light sources. The excited molecules release
the absorbed photon energy through nonradiative relaxation,
inducing a small local temperature rise. This leads to a local
pressure increase, which then relaxes resulting in the propagation
of ultrasound (photoacoustic) waves throughout the tissue; these
waves can be detected by ultrasonic transducers at the surface of
the tissue.
PA image reconstruction essentially converts the detected
time-resolved ultrasound signals back to the optical absorption
distribution in space, a procedure similar to the Global
Positioning System. This is a two-step problem involving
first, reconstruction of the initial acoustic pressure distribution
(the acoustic inverse problem) and second, recovery of the opti-
cal absorption distribution (the optical inverse problem). Various
reconstruction approaches7 have been employed from the sim-
plest and fastest method of back-projection,8,9 to more complex
approaches that can account for arbitrary scanning geometries,
such as model-based linear inversion,10 iterative methods,11
time-reversal, and fast Fourier transform-based methods.12,13
Solution of the optical inverse problem for accurate quantifica-
tion of the optical absorption distribution remains challenging14
but is essential for quantitative molecular imaging (discussed
further in Sec. 4).
PAI is a highly scalable imaging modality, achieving different
spatial resolutions and imaging depths based on different configu-
rations of: light sources; ultrasonic detection systems; and scan-
ning mechanisms.15,16 Based on the image formation method,
PAI can be roughly classified into: photoacoustic microscopy
(PAM) with single-element ultrasonic detection and direct image
formation; or photoacoustic computed tomography (PACT) with
multielement ultrasonic detection and inverse image reconstruc-
tion (see Fig. 2). Both image resolution and tissue attenuation
scale with increasing ultrasound detection frequency. In general,
PAM, with high-frequency ultrasound detection at tens of MHz,
provides micron-resolution images with penetration depths up to
several millimeters, whereas PACT, with low-frequency ultra-
sound detection at a few MHz, is capable of deep-tissue imaging
with centimeter penetration and submillimeter resolutions.*Address all correspondence to: Sarah E. Bohndiek, E-mail: seb53@cam.ac.uk
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3 Genetic Reporters used in Photoacoustic
Imaging
3.1 Production of Cells Expressing Reporter
Proteins
The production of genetically modified mammalian cells
involves transfection, which is the general term describing a pro-
cedure for introducing foreign nucleic acids, such as those con-
stituting a RG, into eukaryotic cells. Transfection methods can
be broadly categorized into those that are transient and others
that are stable, illustrated in Figs. 3(a) and 3(b) respectively.
Transient transfection (TT) is relatively straightforward, involv-
ing the introduction of DNA into cells along with an agent that
promotes its uptake. However, since the foreign DNA is not
integrated into the host genome, the sequence is gradually lost
after repeated cell divisions leading to gene expression that lasts
only a few days. Alternatively, stable transfection entails inte-
gration of the foreign genetic material into the host genome
giving rise to long-term expression of the sequence of interest
as it is propagated in subsequent cell generations.
Methods for TT are generally physical or chemical.17 The
most commonly used physical method is electroporation,
which can rapidly transfect large numbers of cells, but only
after an experimentally demanding determination of the
optimum conditions. PAI studies to date have predominantly
used chemical methods for TT. These methods include use of
a cationic liposome,18 a cationic lipid,19 or calcium phos-
phate,20 and are widely available but may vary in their toxicity
and efficiency according to the cell type. The RG can be coex-
pressed with an antibiotic resistance gene and/or a fluorescent
marker such as EGFP or an inert membrane tag such as the
truncated nerve growth factor receptor (dNGFR). These enable
successfully transfected cells to be selected by their survival
in the presence of antibiotic, and also the reporter protein
expression level to be identified using flow cytometry of the
coexpressed marker.
Stable transfection typically involves virus-mediated gene
delivery,21 which is also known as transduction. The first step
in the transduction process is to transfect three or four plas-
mids—one envelope vector, one or two packaging vectors, and
the transfer vector containing the RG—into packaging cells
such as human embryonic kidney 293T cells (HEK293T).
The virus is then harvested from these cells and used to
infect the target cells, resulting in incorporation of the RG
sequence into the host DNA. Photoacoustic RG studies have
employed common viral vectors including lentiviruses20,22 and
retroviruses.23,24 Lentiviruses are more versatile since they
transduce nondividing cells, unlike retroviruses, which require
replicating cells for transduction. A third viral vector system
that has been used is the vaccinia virus,25 but this is limited
to transient protein production since the virus replicates in
the cytoplasm outside the nucleus and the infected cells only
survive for one or two days.
3.2 Classes of Reporters
PAI RGs can be classified as indirect (enzymatic, which result in
nonfluorescent proteins, Sec. 3.3) or direct (fluorescent and
nonfluorescent proteins, Sec. 3.4). These classes are shown
in Fig. 4, and their spectra are given in Fig. 5. Enzymatic RGs
provide inherent signal amplification, as a single enzyme can
create multiple molecules of absorbing product, whereas direct
RGs provide 1∶1 stoichiometric mapping between the amount
of detected protein and the level of RG expression. Table 1
makes further comparisons between the different classes of
reporters. The ideal reporter should be: specific to the biological
process of interest; exhibit an absorption maximum in the tissue
optical window for deep in vivo imaging; be nontoxic to the cell;
and avoid photobleaching. The reviewed RGs, including optical
properties and demonstrated applications, are discussed in the
following two sections and summarized in Table 2.
3.3 Enzymatic Reporters
Three enzymatically generated reporters have been introduced
for PAI: (1) 5,5′-dibromo-4,4′-dichloroindigo, a blue precipitate
produced via the enzyme β-galactosidase (encoded by the
lacZ gene), which metabolizes X-gal; (2) eumelanin, a brown
pigment produced through action of the tyrosinase enzyme on
Fig. 1 Comparison of the performance of PAI with that of optical and
ultrasonic modalities in terms of their imaging depth and spatial
resolution. PAM, photoacoustic microscopy; PACT, photoacoustic
computed tomography; US, ultrasound imaging.
Fig. 2 Schematics of representative PA imaging implementations,
illustrating PAM and PACT. In PAM, the spatial resolution can be
defined optically (OR-PAM) or acoustically (AR-PAM). Both OR-PAM
and AR-PAM use raster scanning of a single-element ultrasound
transducer to achieve volumetric imaging, shown here in reflection
mode. PACT uses an ultrasound transducer array to detect PA waves
emitted at multiple view angles simultaneously.
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tyrosine; and (3) violacein, a violet pigment produced from
L-Tryptophan via the action of a five-enzyme operon.
LacZ. LacZ is the earliest example of a PAI reporter.44 It
expresses β-galactosidase, an Escherichia coli enzyme involved
in the metabolism of lactose. Injection of X-gal, a colorless
analogue of lactose, leads to formation of a blue product (5,5′-
dibromo-4,4′-dichloroindigo) after cleavage by β-galactosidase
[Fig. 6(a)]. The blue product is strongly absorbing between
Fig. 3 Schematics illustrating (a) TT and (b) stable transfection of an RG into a mammalian cell. The
gene must first be introduced into the target cell (for example, by electroporation), and subsequently into
the nucleus: these two steps represent TT. The recombinant protein is expressed but after cell division
the DNA is only passed on to one of the daughter cells, resulting in the dilution of the RG with subsequent
divisions. Stable expression over successive cell generations is achieved by integration of the RG into
the target cell’s chromosomal DNA (b). This process typically involves lentiviral or retroviral vectors,
which are produced by packaging cells such as HEK293T. The viral genes are expressed by several
plasmids (also called vectors): (i) an envelope vector encoding the vesicular stomatitis virus (VSV-G)
envelope gene; (ii) one or two packaging vector(s) encoding the pol, gag, rev, and tat viral genes;
and (iii) a viral expression plasmid (transfer vector) containing the psi Ψ packaging sequence and
the RG. Approximately 2 days after transfection of HEK293T cells, the cell supernatant contains recombi-
nant viral vectors, which can be used to transduce the target cells. Once in the target cells, the viral
RNA is reverse-transcribed (A), imported into the nucleus and stably integrated into the host genome.
The RG is transcribed into mRNA (B) and then translated into the reporter protein (C). Expression of
the recombinant protein can be detected 1 or 2 days after integration of the viral RNA.
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600 and 700 nm. Dual-wavelength PAM42,45 and PACT45 have
been used to detect gliosarcoma cells expressing the lacZ gene
under the rat scalp; however, X-gal requires local administration
as systemic delivery is inefficient,44 which has discouraged
further PAI studies with the lacZ gene.
Tyrosinase. Tyrosinase oxidizes tyrosine to dopaquinone,
which then undergoes several reactions that lead to melanin
pigments [Fig. 6(b)]46 including eumelanin and pheomelanin.
Eumelanin exhibits a broad extinction coefficient spectrum
(similar to that of pheomelanin), with absorption extending
into the near-infrared, enabling it to be detected above the back-
ground hemoglobin signal at wavelengths between 600 and
700 nm.18,24,47 Paproski et al.18 were the first to develop tyro-
sinase as an RG for PAI. They subsequently developed an
inducible system, in which tyrosinase expression was triggered
by doxycycline administered in the animals’ drinking water.47
The tyrosinase reporter has also shown multimodal imaging
potential48 as eumelanin can bind heavy metal ions (Fe3þ)
detectable with MRI, and a melanin-targeted 18F-P3BZA probe
for positron emission tomography. Stritzker et al.25 also
explored multimodal tyrosinase imaging by TTof tumor bearing
mice with a vaccinia virus encoding tyrosinase. This approach
offers clinical relevance but prevents longitudinal studies. To
maintain tyrosinase expression in subsequent generations of
cells requires modification of the cell genome, which, although
ethically unapproved for clinical studies, does allow longi-
tudinal animal imaging. Jathoul et al.24 achieved this using
stable retroviral transduction, which enabled tumor growth
to be monitored over periods up to 52 days, with apparently
little effect on cell viability [Fig. 4(a)].
Violacein. The deep violet chromophore violacein is enzy-
matically generated [Fig. 6(c)] from the sole precursor trypto-
phan by five enzymes (VioA-E) that were originally cloned
from Chromobacterium violaceum. Violacein has a strong
absorption peak around 575 nm, enabling differential detection
through dual-wavelength excitation at 490 and 650 nm.
However, while tyrosinase and lacZ have been expressed in
mammalian cells, the violacein operon has so far only been
expressed in bacteria.50 Violacein may, therefore, find applica-
tion for in vivo imaging of bacterial infections or theranostic
applications, but concerns remain about the toxicity to mamma-
lian cells.
3.4 Nonenzymatic Reporters: Fluorescent,
Nonfluorescent, and Photoswitchable Proteins
Nonenzymatic reporters can be classified by their optical
properties and according to their natural origins, such as marine
creatures and bacteria [Figs. 5(a)–5(c), Fig. 7]. In general, non-
fluorescent proteins are preferable since they exhibit higher
photoacoustic generation efficiency and significantly higher
photostability (Fig. 8).
3.4.1 Fluorescent proteins
Since the discovery of green fluorescent protein (GFP), fluores-
cent proteins have been widely applied in biomedical studies,
mostly imaged by fluorescence microscopy.27,51,52 GFP-like
proteins are derived from anthozoa (such as sea anemones and
corals) or scyphozoa (jellyfish) and have a common structure
consisting of a β-barrel scaffold containing the chromophore,
which is formed by folding of the polypeptide chain.53 Within
the barrel the chromophore is protected from the outside envi-
ronment, making it possible to genetically engineer the chromo-
phore microenvironment, for example, to produce enhanced
brightness (EGFP)54 or spectral modifications. Razansky et al.26
reported the first demonstration of PAI using EGFP and
mCherry in fruit fly and adult zebrafish [Fig. 4(b)]. The absorp-
tion peaks of even the furthest red-shifted GF homologues35,55
are generally restricted to the visible wavelength region, making
them well suited to PAM but less applicable for PACT deep
in vivo imaging [Fig. 5(a)].
In recent years, several near-infrared fluorescent proteins
(IFPs) have been derived from bacterial phytochrome photore-
ceptors (BphPs).56 These are targeted toward deep tissue in vivo
imaging, exploiting the optical window where endogenous
chromophores have relatively low absorption between 620
and 950 nm [Fig. 5(d) and 5(e)]. BphPs incorporate a far-red
absorbing bilin, biliverdin (BV), as their chromophore, which
is ubiquitous in most eukaryotic organisms. The overall struc-
ture of the BphP photosensory module consists of two or three
protein domains linked by α-helices (Fig. 9), which may exist as
a monomer, dimer, or oligomer. As with GFP-like proteins,
monomers are preferable and several monomeric IFPs have
been developed.57–59 Compared to GFP-like proteins, BphPs
Fig. 4 Selected studies of PA RG imaging. (a) PA image of a tyrosinase-expressing tumor (shown in
yellow) after subcutaneous injection into the flank of a nude mouse.24 The surrounding blood vessels are
shown in gray. (b) Left: fluorescent histology of the brain of a transgenic zebrafish expressing mCherry
(shown in color); right: corresponding PA image.26 (c) PA image of a kidney tumor expressing reversibly
switchable nonfluorescent bacterial phytochrome BphP1.19 The tumor is shown in color, and the back-
ground blood-rich organs are shown in gray. Hb, hemoglobin.
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Fig. 5 Summary of all spectra for genetically encoded reporter proteins demonstrated for PAI.
(a) Fluorescent proteins: EGFP,26,27 DsRed,28 mCherry,29 mKate2,30 AQ143,31 mRaspberry,32
mNeptune,33 eqFP670,34 E2-Crimson,35 TagRFP657,36 iRFP670,37 iRFP713 (iRFP),37 iRFP720.37
(b) Chromoproteins: E2-Crimson NF;23 ultramarine;38 aeCP597;31 cjBlue.39 (c) Photoswitchable proteins:
rsTagRFP;19 AGP1;22 BphP1.19 (d) Molar extinction coefficients and (e) specific extinction coefficients
are compared to oxyhemoglobin (HbO2, 150 gl−1, red dashed line
40) and deoxyhemoglobin
(Hb, 150 gl−1, blue dashed line,40) as well as enzymatic reporters: eumelanin [also endogenous,
black line;41 blue precipitate product of lacZ (blue line,42)]; violacein (yellow line43). Reporter spectra
were generated from published excitation spectra, normalized to the excitation maximum and multiplied
by the relevant peak molar extinction coefficient. Wavelengths indicate absorption maxima.
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exhibit several advantages for PAI,60 such as a relatively low
fluorescence quantum yield (∼6% for iRFP compared to
60% for EGFP) and a high intrinsic extinction coefficient
(∼100;000M−1 cm−1 for iRFP, compared to ∼56;000M−1 cm−1
for EGFP).
The BphP iRFP713 (also known as simply iRFP61) was the
first to be demonstrated in PAI. iRFP expressed in tumor cells
inoculated in the mammary fat pad efficiently incorporated
endogenous BV, and an imaging depth of 4 mm was achieved
exploiting the peak iRFP absorption of 690 nm.62 Two sub-
sequent studies at similar penetration depths imaged mouse
brain tumors expressing iRFP71363,64 and illustrated spectral
resolution of two variants of iRFP (iRFP670, 645 nm peak and
iRFP720, 702 nm peak37) as well as background hemoglobin
signals.65 Despite this improved penetration depth of imaging
compared to GPF-like fluorescent proteins, the photostability
of BphPs remains low, due not only to photobleaching but
also to transient absorption effects.66,67 Furthermore, while their
low fluorescence quantum yield is attractive for PAI, fluorescent
emission and ground state depopulation can lead to low PA sig-
nal generation efficiency. This may partly explain the observed
discrepancies between the measured absorption and photo-
acoustic spectra of these proteins.23
3.4.2 Nonfluorescent proteins (chromoproteins)
Challenges with photobleaching and low PA signal generation
has led to efforts to develop nonfluorescent (or very weakly
fluorescent) proteins, also called chromoproteins [Fig. 5(b)].
Those reported to date are a subset of GFP-like proteins, which
have been identified in Anthozoa species31,38,39 or mutated from
their fluorescent equivalents.23 Chromoproteins exhibit higher
PA signal generation efficiency due to the absence of radiative
relaxation and ground state depopulation, as well as significantly
higher photostability (Fig. 8).23,68 PAI of the chromoprotein
reporter ultramarine has been demonstrated in vivo68 in the rat ear.
3.4.3 Photoswitchable proteins
Photoswitchable proteins undergo a change in their absorption
spectra under illumination with a specific wavelength [Fig. 5(c)].
The mechanism behind this change is typically a cis-trans isomer-
ization of the chromophore. For the BV chromophore used in
BphPs, the two conformations are referred to as Pr (“pigment
red absorbing,” also termed the OFF state) and Pfr (“pigment
far-red absorbing,” or the ON state)56 (Fig. 10). In the unbound
state, switching does not affect the absorption properties of BV,
but when covalently bound to the protein barrel the two isomeric
states exhibit distinct absorption spectra. This property has been
exploited in a comprehensive study of a photoswitchable protein
BphP1 derived from the bacterial phytochrome RpBphP1.19 By
taking the pixelwise subtraction between the images of the protein
in the OFF and ON states, a ∼21 fold enhancement in the con-
trast-to-noise ratio (difference between proteins and blood) was
obtained relative to the ON-state image. This differential imaging
enabled visualization of BphP1-expressing U87 cells in the left
kidney in PACTat depths up to ∼8 mm, with an average CNR of
∼20. The photoswitching property was exploited to perform sub-
diffraction imaging of individual cells in PAM, as BphP1 mole-
cules are switched off at a rate proportional to the local excitation
intensity, which is greater in the centre of the Gaussian-shaped
laser pulse than at the periphery. In addition to this study,
which illustrates the versatility of photoswitchable proteins for
high contrast in vivo imaging, a preliminary demonstration has
recently emerged of a second BphP derived photoswitchable pro-
tein, AGP1.22 Various photoswitchable proteins have also been
derived from corals (GFP-like),69 two of which have been dem-
onstrated for PAI: rsTagRFP19 and Dronpa.70 With absorption
peaks at wavelengths <570 nm, these proteins are most suitable
for studies in PAM.
4 Recovering the Spatial Distribution of
Genetic Reporters
Compared to fluorescence imaging of RGs, PAI can be easily
performed at multiple wavelengths to specifically resolve the spa-
tial distribution of overlapping absorption spectra. Nonetheless,
achieving such spectral resolution through mathematical
“unmixing” procedures is nontrivial since there are multiple
endogenous absorbers present in tissue that also contribute to
the signal. The position (r) and wavelength (λ) dependent absorp-
tion coefficient μaðr; λÞ may be written as the sum of the individ-
ual molar extinction coefficients ϵkðλÞ of the K contributing
chromophores with molar concentrations ckðrÞ, k ¼ 1; : : : ; K
EQ-TARGET;temp:intralink-;e001;326;102μaðr; λÞ ¼
XK
k¼1
ckðrÞϵkðλÞ: (1)
Table 1 Summary of the key features of different groups of RGs
investigated in PA imaging.
Indirect reporters (enzymatic):
✗ Low absorption coefficient, but. . .
✓ Inherent signal amplification: one enzyme molecule can
create multiple molecules of absorbing product
✓ Not susceptible to photobleaching
Direct reporters (nonenzymatic):
✓ Provide 1∶1 mapping between the detected protein and
the RG expression
– GFP-like fluorescent proteins:
✗ Susceptible to photobleaching
✗ Absorption maxima typically overlap with high blood
attenuation, preventing deep tissue imaging
– Fluorescent proteins from phytochromes:
✗ Typically require a cofactor (although this is not
a problem in mammals)
✓ Less susceptible to photobleaching
✓ Allow deep tissue imaging (absorption in the NIR)
– Nonfluorescent proteins (chromoproteins):
✗ Not yet efficiently expressed in mammalian cells
✓ Not susceptible to photobleaching;
✓ High PA signal generation efficiency
– Photoswitchable proteins:
✓ Reversibly photoconvertible between red and NIR absorption
states; image subtraction improves contrast, background
removal, and spatial resolution
✓ NIR absorption for deep tissue imaging
✓ No photobleaching even at fluences above the MPE
Note: NIR, near-infrared; MPE, maximum permissible exposure.
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Fig. 6 Schematics showing the reaction pathways of three enzymatic reporters. (a) The hydrolysis of
X-gal catalyzed by β-galactosidase, an enzyme produced from the lacZ RG. (b) Reactions leading from
tyrosine to the pigment eumelanin. The enzyme tyrosinase, produced from the tyrosinase RG, oxidizes
tyrosine to dopaquinone, which then undergoes various enzymatic and nonenzymatic reactions (repre-
sented by the dashed line) leading to eumelanin. Dopa, 3,4-dihydroxyphenylalanine. (c) The violacein
biosynthesis pathway.49 IPA, indole-3-pyruvic acid.
Fig. 7 Classification and origins of nonenzymatic fluorescent (wavelengths of absorption and emission
maxima given), nonfluorescent (only absorption maxima), and photoswitchable (↔) reporter proteins
used in PAI. The colors indicate the corresponding wavelengths. Full molar extinction spectra are
given in Fig. 5.
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The spectra of ϵkðλÞ are often known or can be measured using
reference spectrophotometers, and so, in principle, it should be
straightforward to recover the concentrations ckðrÞ frommeasure-
ments of μaðr; λÞ. In practice, however, the PA signal Pðr; λÞ is
not a direct measurement of μaðr; λÞ alone; rather, it is a combi-
nation of: the optical energy Hðr; λÞ deposited in tissue;
a proportionality constant αðrÞ arising due to the imperfect
response of the PAI hardware used to record the acoustic data;
and the Grüneisen parameter ΓðrÞ, which is a dimensionless
coefficient representing the efficiency of the conversion from
heat to pressure
EQ-TARGET;temp:intralink-;e002;326;490Pðr; λÞ ¼ αðrÞΓðrÞHðr; λÞ: (2)
For in vivo imaging, the parameters αðrÞ and ΓðrÞ are commonly
assumed to be spatially constant (i.e., α, Γ) and invariant
with wavelength,47 giving a direct proportionality between the
absorbed energy density map Hðr; λÞ and the detected PA signal
Pðr; λÞ. However, Hðr; λÞ is the product of the fluence Φ, which
itself varies as a function of r and λ, as well as μaðr; λÞ and the
reduced scattering coefficient μ 0sðr; λÞ
EQ-TARGET;temp:intralink-;e003;326;382Hðr; λÞ ¼ μaðr; λÞΦ½r; λ; μaðr; λÞ; μ 0sðr; λÞ: (3)
Recovery of μaðr; λÞ from Eq. (3) is an ill-posed and nonlinear
inversion, in which Φ is normally unknown. Therefore, recovery
of μaðr; λÞ from Pðr; λÞ remains a key challenge for quantitative
evaluation of RG concentrations ckðrÞ from PA images.
Nonetheless, resolving the spatial distribution and relative signal
weighting for cells expressing PAI RGs may be achieved by
(Table 3): (1) peak wavelength imaging; (2) spectral unmixing;
or (3) difference imaging. The first approach simply maps the
Fig. 8 Photostability of eumelanin-producing cells (the cells express the enzyme tyrosinase), compared
with photobleaching of fluorescent and nonfluorescent proteins under prolonged exposure to nanosec-
ond laser pulses. The incident fluence was in the range 1.5 to 1.7 mJcm−2 and the pulse repetition
frequency was 50 Hz. Reproduced with permission from Refs. 23 and 24.
Fig. 9 Domain structure of BphPs. The photosensory module con-
sists of PAS, GAF, and PHY domains. The chromophore BV is
located in a pocket of the GAF domain and is covalently bound to
the cysteine (Cys) residue of the PAS domain. Upon light absorption
BV undergoes a conformational change that is detected by the
photosensory module, which then transmits the signal to the effector
domain, initiating the light driven molecular signaling pathway.
Adapted from Ref. 56.
Fig. 10 Photoswitching of the BV chromophore between the Pfr (ON) and Pr (OFF) states. Switching
from ON to OFF and vice versa is induced by illumination with NIR light (∼730 to 790 nm) and far-red light
(∼630 to 690 nm), respectively, and involves an out-of-plane rotation of the D pyrrole ring around
the C 15/16 bond between the C and D rings. Adapted from Ref. 19.
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Table 3 Summary of methods used to separate chromophores in PA imaging.
Method Details, advantages, ⊕ and disadvantages ⊖ References
Peak λ imaging Maps Hðr; λÞ by thresholding signals at a λ where the chromophore
μa ≫ background absorption
18, 24, 44,
45, 48, and 50
⊕ Simple to implement and fast to compute
⊖ Arbitrary threshold; signal may be lost in background
Linear inversion Hðr; λÞ is divided byΦest; chromophores are then separated by least squares regression
• Φest calculated Assumes homogeneous background optical properties 26 and 62
⊕ Simple to implement and fast to compute
⊖ Limited accuracy for nonsuperficial tissue layers 79
• Φest determined experimentally ⊕ Potential for Φest to accurately estimate Φ
⊖ No approach seems practical for in vivo measurements:
→ Black absorber inserted invasively 80 and 81
→ DOT only gives a low resolution fluence map 82
→ Poor speckle contrast for AO assisted fluence correction 83
• Φest modeled and
μa recovered iteratively
Light transport model using assumed μ 0s and initialized μa to give Φest and Hest;
iterative optimization relative to Hðr; λÞ
→ Simulations, phantoms, and in vivo studies have used the RTE,
or its diffuse approximation
84–88
⊕ Potential for Φest to accurately estimate Φ
⊖ Distribution of μ 0s is often unknown in vivo
Nonlinear model-based inversion Iterative search for combinations of μa and μ 0s that minimize the difference between
Hðr; λÞ and Hest
89 and 90
⊕ General method for recovery of absolute ck ðrÞ
⊕ Little prior information required
⊖ Nonunique values for ½μa; μ 0s give identical Hest
requiring workarounds such as multiple illuminations 91–93
⊖ Many variables, occupying extensive computer memory
Semiquantitative, blind unmixing Use statistical properties of chromophore distributions to unmix relative contributions
rather than absolute ck ðrÞ
→ Vertex component analysis 94
→ AMF 95 and 96
→ PCA 97
→ ICA 63 and 98
⊕ Can provide more accurate results than linear inversion
⊕ Easy to implement and low computational cost
⊖ Requires correction for spectral coloring
⊖ Cannot estimate absolute ck ðrÞ
Novel decomposition methods Separate μa from Φ without using light transport models
⊕ No fluence modeling required;
⊖ Usually complex; not yet generally applicable in vivo
→ Sparse representations based on spatial characteristics 99
→ Linear superposition of reference fluence base spectra 100
→ “Differential” PA signal generated by two different λ 101
Difference imaging Pixelwise subtraction of images acquired with a photoswitchable reporter in
two different absorption states
19, 22, 70, and 76
⊕ No knowledge of the fluence required
⊕ Enables resolution enhancement in OR-PAM 19
⊖ Only possible for photoswitchable reporters
Note: AO, acousto-optics; DOT, diffuse optical tomography; RTE, radiative transport equation. ck ðrÞ, chromophore concentrations; Hðr; λÞ,
absorbed energy density; Hest, estimated Hðr; λÞ; λ, wavelength; μa, absorption coefficient; μ 0s , reduced scattering coefficient; Φest, estimated
fluence. AMF (adaptive matched filter), PCA (principal component analysis), and ICA (independent component analysis).
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spatial distribution of signals above the background at a wave-
length where the absorption of the chromophore of interest is
high, but the background absorption dominated by the hemo-
globins is relatively low.18,24,44,45,48,50 The latter approaches are
more complex, as discussed below.
4.1 Spectral Unmixing
Spectral unmixing takes advantage of the multiwavelength data
acquisition capability of PAI, applying multivariate analysis
techniques to retrieve abundance maps of the individual absorb-
ers present in the tissue (Fig. 11). First, the aforementioned
challenge of unknown light fluence Φ must be accounted for,
which is usually achieved with the addition of a preprocessing
step. Multiwavelength PA data are typically divided by an esti-
mated value of the fluenceΦestðr; λÞ to give images proportional
to μaðr; λÞ. For imaging of the superficial tissue layers in PAM,
the light fluence Φ may be assumed to be spectrally constant71
and can be estimated experimentally, for example, by invasively
inserting a film with uniform absorption to correct for absorption
by the dermis.80,81 For applications in PACT, a simple finite-
element method solution to the light diffusion equation assuming
homogeneous background optical properties can be applied to
deriveΦestðr; λÞ.26,55,62,65 More rigorous approaches to deal with
this “spectral coloring” in PACT include Monte Carlo simula-
tions and model-based iterative minimization;84–90 however, these
methods are computationally intensive and may give rise to
nonunique solutions. As a result, they are not routinely applied
during in vivo imaging.
Having dealt with the data preprocessing, most RG studies
perform linear inversion using a form of least-squares regres-
sion,26,55,62,65 in some cases with constraints for positive concen-
tration values exceeding some threshold.47,68 These least-squares
approaches rely on a priori knowledge of the absorption spectra
present within a given voxel. Where these are not well known,
for example, when the spectra change as a function of concen-
tration, semiquantitative “blind” methods that use the inherent
statistical properties of the spectral data can be employed. Some
examples relevant to RG imaging include: principle component
analysis (PCA);97 independent component analysis (ICA);63,98
vertex component analysis;94 and adaptive matched filter
(AMF).64,95 Only AMF64 and ICA63 have been applied in
PAI of RGs; both methods were able to resolve brain tumors
in mice expressing iRFP713. Tzoumas et al.64 assessed the
impact of the number of excitation wavelengths and different
unmixing algorithms on the detection sensitivity for the RG,
although their findings contradict prior studies suggesting that
the optimum number of wavelengths and unmixing algorithm is
likely to be case sensitive.95
4.2 Difference Imaging
Spectral unmixing is hampered by fundamental requirements:
the preprocessing must be accurate to compensate for light
fluence, and the data must have sufficient signal-to-noise
ratio (SNR) to avoid corruption of the spectral profile. The
recent emergence of photoswitchable nonfluorescent proteins
[Fig. 4(c), Sec. 3.4]19,22,70 mitigates these limitations by switch-
ing the protein ON/OFF state between image acquisitions.
Taking the difference of images acquired at the same wavelength
but with different protein states effectively eliminates the non-
switchable background signals, minimizing the effect of the
local optical fluence.76 As a result, photoswitchable reporters
achieve reliable background removal and have been shown
to dramatically enhance the detection sensitivity (∼34-fold
enhancement in contrast-to-noise ratio compared to two-
wavelength least-squares fitting19). For applications requiring
quantification of protein concentration, rather than only quali-
tative spatial localization, photoswitchable reporters therefore
represent an ideal solution.
5 Detection Sensitivity
The ability to detect and resolve RGs in vivo relies on sufficient
sensitivity in the PAI hardware, as well as biological consider-
ations, such as gene expression levels and spectral characteris-
tics of the reporter.
5.1 Imaging System Sensitivity
For molecular PAI, spatial resolution and penetration depth have
to be traded to optimize the detection sensitivity. One parameter
used to quantify detection sensitivity is the noise-equivalent
detectable concentration (NEC).79 NEC is calculated as the con-
centration of the imaged molecules normalized by the SNR. To
achieve a low NEC, one can increase the excitation light fluence
(within the maximum permissible exposure, MPE) to increase
the SNR. Since the SNR of PAI is proportional to the total num-
ber of molecules in a resolution voxel, relaxing the spatial
Fig. 11 Multispectral PA imaging. Images at multiple wavelengths (λ) are combined with spectral unmix-
ing algorithms to separate different absorbers. Hb, deoxyhemoglobin HbO2, oxyhemoglobin reporter
example, iRFP713. Adapted from Ref. 102.
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resolution can also improve the NEC, as long as the local optical
fluence is maintained. Counter-intuitively, this means that
PACT systems, which generally have worse spatial resolution,
typically have a better NEC than PAM systems, provided that
the light pulse energy is sufficient.
The detection sensitivity of PAI is generally lower than that
of pure optical imaging modalities by at least two orders of
magnitude.79 This is somewhat surprising considering that, at
the source (the imaged target), the overall energy conversion
efficiencies of fluorescence and PA imaging are similar: for a
fluorescent absorber, the transfer of energy from the absorbed
photons to fluorescent emission is typically less than 30% effi-
cient, determined by the fluorescent quantum yield, and the
remaining absorbed optical energy is deposited as thermal
energy, which is subsequently converted to acoustic energy
with an efficiency of ∼20% at body temperature, determined
by the Grüneisen coefficient.82 The difference in sensitivity
between the two imaging modalities is largely a consequence
of the detectors. While a photomultiplier tube used in fluores-
cence imaging may have single-photon sensitivity, a typical
ultrasonic transducer has a noise-equivalent pressure (NEP)
of ∼2 Pa,83,91 which is equivalent to a temperature rise at the
target of ∼2 μK. Within the skin MPE (20 mJ∕cm2), the
noise equivalent absorption coefficient (NEμa) of the target is
∼0.001 cm−1. For EGFP with a molar extinction coefficient
of 56;000 M−1 cm−1 and quantum yield of 60% at 488 nm,
this NEμa roughly translates to an NEC of 0.1 μM. When
the geometric signal loss from the target to the ultrasonic trans-
ducer is taken into account,91,92 the NEC approaches several
micromolars, which is generally consistent with experimental
results and much higher than that of native proteins in cells.79
By contrast, the detection sensitivity of fluorescence microscopy
is on the level of several nanomolars, close to the natural con-
centrations of native cell components.
Fundamental limitations on recorded PA signals are: PA
detection sensitivity; PA signal generation efficiency; and the
tissue optical and acoustic attenuation. Fortunately, the acoustic
sensitivity of ultrasound detectors can be enhanced by better
matching their detection bandwidth with the broadband
PA signal spectrum. While the detection sensitivity of a con-
ventional piezoelectric ultrasonic transducer degrades with
decreasing element size, the sensitivity of optical sensors of
acoustic waves, typically based on interferometry, does not.
Therefore, optical detection holds promise for high-sensitivity
PACT, especially for the cases where the elements of the ultra-
sonic transducer array are miniaturized to achieve isotropic
resolutions.93,96,99
5.2 Reporter Detectability
For PAI at depths more than 1 mm, the reporter protein should
have an absorption maximum within the tissue optical window
(620 to 950 nm) where mammalian tissues are relatively
transparent due to the low optical absorption by water, lipids,
hemoglobin, and melanin. Even with such optimization of the
reporter protein absorption wavelength, the strong background
signal from blood still presents a challenge for PA RG imaging,
since hemoglobin concentration in tissue is ∼2.3 mM.100 The
problem is shown in Figs. 5(d) and 5(e), which compares
the molar extinction spectra and specific extinction spectra
for the hemoglobins and a selection of enzymatic and direct
PAI reporters. The molecular mass of enzymatically produced
proteins is more than two orders of magnitude smaller than
the molecular mass of the hemoglobins and directly produced
proteins, such as mCherry or BphP1. Thus, care must be
taken when comparing required reporter concentrations in terms
of moles, grams, or gene-expressing cell numbers. As an
example of the challenges of reporter detectability, while the
absorption maximum of BphP1 is in the tissue optical
window, if the protein concentration is two orders of magnitude
lower than hemoglobin concentrations, it remains a challenge to
detect a signal above the hemoglobin background. Nonetheless,
proteins derived from bacterial phytochromes (iRFP670 and
iRFP720) have been detected at estimated concentrations
in vivo of 16 to 30 μM,65 although the effect of such high
concentrations on cell biology remains unknown.
6 Potential Applications
RGs for PAI have the potential to be applied in a variety of fun-
damental biomedical studies that require high spatial resolution
at extended penetration depths. Examples include but are not
limited to: (1) visualizing the expression of genes of interest;
(2) understanding signal transduction pathways and protein–
protein interactions;101 (3) longitudinal monitoring of tumor
growth,24,19 (4) tracking the in vivo distribution of administered
cells (e.g., therapeutic immune cells); (5) probing distance-
dependent interactions between two proteins (Förster resonance
energy transfer);68 and (6) reporting on environment change due
to biochemical activities (e.g., calcium ion concentration).
Furthermore, complementing functional PAI of neuronal
activities in deep brain (>2 mm) using hemoglobin signals,103
novel genetic reporters of action potentials or surrogates
(e.g., voltage-, or calcium-sensitive proteins) would be of great
advantage104 and could potentially be engineered from non-
fluorescent near-infrared BphPs.105 An additional future area of
interest could be development of PAI optogenetic sensors to
modulate neuronal activities in deep brain, where the light-
mediated control of protein–protein interactions could be
monitored at high resolution.106
7 Challenges and Prospects
PAI has filled a void of high-resolution optical imaging in deep
tissue, opening the potential for biomedical studies that require
high-resolution RG imaging at depths beyond the optical diffu-
sion limit. Moreover, the use of nonionizing radiation in PAI
allows longitudinal molecular imaging of the same animal,
enabling informative observations of disease progression or
drug efficacy. The properties of existing reporters are compared
in Table 1. Chromoproteins are promising given their high PA
signal generation efficiency but have not yet been expressed
efficiently in mammalian cells. So far, despite requiring tailored
instrumentation, photoswitchable proteins show the greatest
potential for deep tissue in vivo PA imaging, since differential
imaging between ON/OFF states removes the endogenous
background signal improving image contrast and SNR.
The major challenges in PAI of RGs are sensitivity and quan-
tification. The detection sensitivity is ultimately limited by the
instrumentation but can be somewhat mitigated by choosing
reporters with favorable absorption characteristics and high
protein expressions levels. Recovering the spatial distribution
of reporters has been approached using two distinct methods.
Spectral unmixing results in large uncertainties and false
positives, mainly due to the unknown light fluence. Using
photoswitchable phytochromes is potentially only limited by
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detection noise. Both approaches remain susceptible to motion
artifacts, which can be overcome by minimizing the time inter-
val between image acquisitions.107–109 The focus for future stud-
ies should be to optimize detection sensitivity and to improve
reporter localization and quantification. This requires technical
improvements in acoustic transducer sensitivity, and addressing
signal unmixing challenges such as the unknown light fluence.
Further biological improvements could develop and optimize
the spectra and extinction coefficients of photoswitchable
reporters applied in difference imaging.
The number of RGs for PAI has expanded dramatically
in recent years with examples of high-resolution and high-
sensitivity detection of reporter proteins now available. Future
developments in PAI hardware and protein engineering will
push the current detection limits further, enabling PAI to emerge
as a modality of choice for longitudinal molecular imaging of
genetic reporters.
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